- Home
- IMA vs CFBK Comparison
IMA vs CFBK Comparison
Compare IMA & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- CFBK
- Stock Information
- Founded
- IMA 2019
- CFBK 1892
- Country
- IMA United States
- CFBK United States
- Employees
- IMA N/A
- CFBK N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- CFBK Major Banks
- Sector
- IMA Health Care
- CFBK Finance
- Exchange
- IMA Nasdaq
- CFBK Nasdaq
- Market Cap
- IMA 159.1M
- CFBK 159.5M
- IPO Year
- IMA N/A
- CFBK 1998
- Fundamental
- Price
- IMA $9.14
- CFBK $25.10
- Analyst Decision
- IMA
- CFBK Buy
- Analyst Count
- IMA 0
- CFBK 1
- Target Price
- IMA N/A
- CFBK $29.00
- AVG Volume (30 Days)
- IMA 41.0K
- CFBK 32.6K
- Earning Date
- IMA 01-01-0001
- CFBK 10-29-2025
- Dividend Yield
- IMA N/A
- CFBK 1.27%
- EPS Growth
- IMA N/A
- CFBK 36.66
- EPS
- IMA N/A
- CFBK 2.77
- Revenue
- IMA $4,300,000.00
- CFBK $52,793,000.00
- Revenue This Year
- IMA N/A
- CFBK $39.98
- Revenue Next Year
- IMA N/A
- CFBK $10.47
- P/E Ratio
- IMA N/A
- CFBK $9.06
- Revenue Growth
- IMA N/A
- CFBK 20.91
- 52 Week Low
- IMA $7.95
- CFBK $19.23
- 52 Week High
- IMA $23.28
- CFBK $31.17
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- CFBK 60.21
- Support Level
- IMA N/A
- CFBK $24.80
- Resistance Level
- IMA N/A
- CFBK $25.97
- Average True Range (ATR)
- IMA 0.00
- CFBK 0.45
- MACD
- IMA 0.00
- CFBK 0.04
- Stochastic Oscillator
- IMA 0.00
- CFBK 48.52
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.